Compare REX AI Equity Premium Income ETF (AIPI) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
REX AI Equity Premium Income ETF vs Cronos Group Inc — how do they compare? REX AI Equity Premium Income ETF trades at $37.25, while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Cronos Group Inc is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| AIPI | CRON | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $44.93 | $3.27 |
52-Week Low | $32.45 | $2.30 |
Market Cap | — | $1.11B |
Enterprise Value | — | $310.67M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AIPI trades at $37.34, up 1.52% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The stock pays high weekly dividends, recently transitioning to this frequency to attract income investors. Key resistance lies at $38, with support at $36.
Outlook is mixed: high dividend yields near 35% offer income appeal, but sustainability concerns and structural risks from option-writing strategies pose challenges. Investors should weigh income benefits against potential NAV erosion if AI market momentum slows.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About REX AI Equity Premium Income ETF
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Read more on AIPI →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
